Rifat Pamukcu
Director, Aprea Therapeutics, Inc.
Companies
- Aprea Therapeutics, Inc.Board member May 26, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aprea Therapeutics, Inc. APRE22,689 shares2$12.8K at $0.56Jun 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Granted 3,135 shares of Aprea Therapeutics, Inc.2
- Jun 5, 2025Granted 1,045 shares of Aprea Therapeutics, Inc.3
- Jun 20, 2024Granted 1,045 shares of Aprea Therapeutics, Inc.4
- Aug 23, 2023Granted 500 shares of Aprea Therapeutics, Inc.5
- Aug 23, 2022Converted 271,870 shares of Aprea Therapeutics, Inc.5
- Aug 23, 2022Converted 49,280 shares of Aprea Therapeutics, Inc.5
- Jul 28, 2022Granted 5,995 shares of Aprea Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 9, 2025
- 4SEC EDGARForm 4 filed Jun 21, 2024
- 5SEC EDGARForm 4 filed Aug 24, 2023
- 6SEC EDGARForm 4 filed Aug 1, 2022